Newsroom
Sorted by: Latest
-
Civeo Awarded Six-Year Western Canada Contract Renewal
HOUSTON & CALGARY, Alberta--(BUSINESS WIRE)--Civeo Corporation (NYSE: CVEO) today announced that one of its Western Canadian based joint ventures has been awarded a six-year contract renewal in Western Canada to continue providing workforce accommodations and hospitality services. The new agreement extends through June 30, 2032, superseding existing arrangements that were scheduled to expire in 2027. Under the renewed agreement, the joint venture will provide safe, reliable and scalable workfor...
-
Civeo Corporation Prices $100.0 Million Convertible Senior Notes Offering
HOUSTON--(BUSINESS WIRE)--Civeo Corporation (“Civeo”) (NYSE: CVEO) today announced the pricing of its offering of $100.0 million aggregate principal amount of 4.50% convertible senior notes due 2031 (the “notes”) in a private offering (the “offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The issuance and sale of the notes are scheduled to settle on July 7, 2026, subject to c...
-
Rosen Law Firm Encourages Alibaba Group Holding Limited Investors to Inquire About Securities Class Action Investigation – BABA
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Alibaba Group Holding Limited (NYSE: BABA) resulting from allegations that Alibaba may have issued materially misleading business information to the investing public.So What: If you purchased Alibaba securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement...
-
MERCADOLIBRE, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against MercadoLibre, Inc. (“MercadoLibre” or the “Company”) (NASDAQ:MELI). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.[LEARN MORE ABOUT THE INVESTIGATION]What Happened?On May 7, 2026, MercadoLibre released its first quarter 2026 financial results and disclosed that lo...
-
Access AdvanceとAlibaba、AlibabaのVDPプールへの参加拡大を発表
ボストンおよび杭州市--(BUSINESS WIRE)--(ビジネスワイヤ) -- Access Advance LLCとAlibaba Groupは本日、AlibabaがAccess Advance Video Distribution Patent Pool(VDP プール)にライセンシーとして加わり、HEVC、VVC、VP9、AV1コーデック技術を包括的にカバーするライセンスを取得したことを発表しました。この発表は、Alibabaがライセンサーおよびライセンシーとして参加しているVVC Advance特許プールと、Alibabaが2025年にライセンサーとして参加したVDPプールを含む、両社の複数年にわたる協力関係における重要な節目となるものです。また、中国有数の動画配信プラットフォームであるAlibaba傘下のYoukuも、2025年にVDPプールへライセンシーとして参加しています。 Alibabaは、eコマース、エンターテイメント、デジタルメディアにまたがる幅広い動画関連サービスを展開し、世界でも有数の多様なビデオエコシステムを構築しています。動画が消費者の購買、コミュニケ...
-
Access Advance and Alibaba Announce Alibaba's Expanded Participation in the VDP Pool
BOSTON & HANGZHOU, China--(BUSINESS WIRE)--Access Advance LLC and Alibaba Group announced that Alibaba has joined the Access Advance Video Distribution Patent Pool (VDP Pool) as a Licensee....
-
Access Advance 与阿里巴巴宣布阿里巴巴进一步扩大参与视频分发专利池
波士顿与杭州--(BUSINESS WIRE)--(美国商业资讯)-- Access Advance LLC 与阿里巴巴集团今日联合宣布,阿里巴巴已加入 Access Advance 视频分发专利池(VDP专利池)成为被许可方,获得覆盖 HEVC、VVC、VP9 和 AV1 视频编解码技术的专利许可。此次宣布标志着双方多年合作迈入新的重要里程碑。双方此前已在 VVC Advance 专利池展开合作,阿里巴巴同时作为许可方和被许可方参与其中;2025 年,阿里巴巴加入 VDP Pool 成为许可方,其旗下优酷作为中国领先的视频流媒体平台之一,也于 2025 年加入 VDP Pool 成为被许可方。 阿里巴巴运营着全球最丰富的视频生态系统之一,视频服务广泛覆盖电子商务、娱乐、数字媒体等多个业务领域。随着视频已成为消费者购物、交流和获取娱乐内容的核心载体,阿里巴巴广泛的视频业务布局,正体现了 VDP Pool 所面向服务的复杂商业模式。 Access Advance 首席执行官 Peter Moller 表示:"一家企业参与视频编解码标准创新、将其专利加入专利池、取得专利许可,并进一步将合作...
-
Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the U.S. Food and Drug Administration (FDA) has approved expanded use of CASGEVY® (exagamglogene autotemcel) for the treatment of people ages 2 years and older with either sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) or transfusion-dependent beta thalassemia (TDT). CASGEVY is the first approved genetic therapy indicated for children as young as 2 years for both SCD and TDT....
-
BBHW Supports DEA Scheduling of 7-OH and Three Related Drugs is an Important Step to Take Dangerous, Synthetic Products Off of the Market
WASHINGTON--(BUSINESS WIRE)--The Drug Enforcement Administration (DEA) announced today that 7-hydroxymitragynine (7-OH) and three related synthetic drugs, pseudoindoxyl, MGM15 and MGM16, are being officially placed on Schedule I of the Controlled Substances Act. This scheduling decision aligns regulation with science, a move Botanicals for Better Health and Wellness (BBHW) strongly supports. “The DEA’s decision to schedule 7-OH and three related drugs sends a clear message to both U.S. consumer...
-
Securities Fraud Investigation Into Cerebras Systems Inc. (CBRS) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Cerebras Systems Inc. (“Cerebras” or the “Company”) (NASDAQ: CBRS) on behalf of investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON CEREBRAS SYSTEMS INC. (CBRS), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.What Is The Investigation About?On May 14, 2026, Cerebras conducted its initial public offering...